• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ)

SYNTRegulatory press release2025-11-22 15:53
Download the release

22 November 2025

SyntheticMR AB (publ) announces today that Marcel Warntjes, at his own request, has decided to resign from his position as a member of the Board of Directors with immediate effect. Marcel Warntjes will remain a member of the Nomination Committee, in his capacity as one of the company's largest shareholders.

"Having founded SyntheticMR almost twenty years ago, I believe the time is now right for me to step down from my role on the Board. The company is entering a very exciting phase in which the continued roll-out of SyMRI 3D, together with the combined technologies of Combinostics and SyntheticMR, has created a strong platform for sustained leadership in the objective quantification of MRI examinations. With CEO Lena Åredal in place, I am confident that the company is well positioned to take the next step, while I look forward to dedicating more time to research," says Marcel Warntjes.

The Board of Directors would like to express its sincere gratitude to Marcel for his extensive and long-standing contributions to the company's development in several key roles over nearly two decades.

For further information, please contact:
Gisli Hennermark, Chairman of the Board, tel. +46 70-420 83 00
Lena Åredal, CEO, tel. +46 76-770 99 08

This disclosure contains information that SyntheticMR AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 22-11-2025 15:54 CET.